L. Y. Wu et al. / Tetrahedron Letters 51 (2010) 402–403
403
6. Suzuki, K.; Watanabe, T.; Murahashi, S. I. Angew. Chem., Int. Ed. 2008, 47, 2079.
7. Heaney, H. Aldrichim. Acta 1993, 26, 35.
O
P
BnO
i. (BnO)2PN(iPr)2
HON
CO2Bn
CO2Bn
BnO
ON
CO2Bn
CO2Bn
5-(ethylthio)-1H-tetrazole
8. All solvents used in the reactions were both anhydrous and obtained as such
from commercial sources. All other reagents were used as supplied unless
otherwise stated. 1H, 13C, and 31P NMR spectra were recorded on either a
Varian Vx 300 or Inova 500 MHz instrument. 1H NMR chemical shifts are
relative to TMS (d = 0.00 ppm), CDCl3 (d = 7.26 ppm), CD3OD (d = 4.87 and
3.31 ppm), or D2O (d = 4.87 ppm). 13C NMR chemical shifts are relative to
CD3OD (d = 49.15 ppm) or CDCl3 (d = 77.00 ppm). 31P NMR chemical shifts in
CDCl3, CD3OD, or D2O were externally referenced to 85% H3PO4 (d = 0.00 ppm)
in CDCl3, CD3OD, and D2O, respectively. Maldi-High resolution mass
spectrometry (Maldi-HRMS) was performed by the Laboratory for Bioanalysis
and Biotechnology Center (LBB2) at Washington State University.
9. General procedure for -oximino acid esters 2: Amino acid HCl salts were
extracted in CH2Cl2 from saturated NaHCO3, washed with brine, and the
resulting organic layer was dried over MgSO4, then concentrated in vacuo.
MMPP (1.1 mmol, 1.1 equiv) was suspended in THF (3 mL), purged with Ar (g),
and stirred at À40 °C. A neutralized amino acid ester (1 mmol) was dissolved in
THF (2 mL) and was added via a syringe to the MMPP solution. The reaction
was stirred for 20 min at À40 °C, the cooling bath was removed, and the
reaction was stirred for an additional 2 h at room temperature. The reaction
mixture was dissolved in ethyl acetate (15 mL), washed thrice with saturated
sodium thiosulfate (15 mL each), washed with saturated sodium bicarbonate
(15 mL), washed with brine (15 mL), and the organic layer was dried over
Na2SO4 and concentrated in vacuo to either a white solid or colorless oil.
10. Yang, S. M.; Lagu, B.; Wilson, L. J. J. Org. Chem. 2007, 72, 8123.
ii. t -BuOOH
2a
3
21%
iii. Pd/C, H2,
NaHCO3
O
–
—O
P
ON
CO2
—O
–
CO2
4
Quant.
Scheme 1. Synthesis of phosphoryl oxime gluatamate.12,13
in Table 1 were neutralized by basic extraction prior to reaction
with MMPP, we were unable to obtain 1g in this form and
consequently we observed considerable overoxidation to the cor-
a-nitro analog. The low yield of 2j is presumably due
to the competing oxidation of the indole nitrogen. Overall, the oxi-
responding
11. Allen, J. F. J. J. Am. Chem. Soc. 1957, 79, 3071.
12. Synthesis of intermediate 3: In a 25 mL round-bottomed flask, acetonitrile
(12 mL) was added to
a mixture of 5-(ethylthio)-1H-tetrazole (216 mg,
dation of most protected amino acids to their respective
acid ester analogs with MMPP gave good yields.
a-oximino
1.658 mmol) and (Z)-dibenzyl 2-(hydroxyimino) pentanedioate (2a, 283 mg,
0.829 mmol) under an Ar(g) atmosphere. The solution was cooled to 0 °C and
dibenzyl N,N-diisopropylphosphoramidite (409 lL, 1.243 mmol) was added
There are limited examples for the preparation of protected
phosphoryl oximes.11 We prepared the phosphorylated
-oximino
acid as shown in Scheme 1.12,13 As a late stage transition state ana-
log peptitometic inhibitor of PSMA, phosphorylated -oximino
acid 4 was found to have an IC50 of 276 nM but when preincubated
with the enzyme for 10 min, the IC50 was enhanced to 58 nM.
slowly. The reaction was stirred for 1.5 h at room temperature, then filtered. To
the resulting filtrate was added 5-(ethylthio)-1H-tetrazole (110 mg,
0.845 mmol) and tert-butyl hydroperoxide solution (70 wt % in H2O, 1 mL) at
0 °C. The reaction mixture was stirred at 0 °C for 10 min, the ice bath was
removed, and the reaction was stirred for an additional 1 h at room
temperature. The reaction mixture was concentrated in vacuo, extracted
with ethyl acetate from saturated NaHCO3, and washed with brine. The organic
layer was dried over MgSO4, filtered, and concentrated in vacuo to give a pale
yellow oil. The product was purified by flash chromatography (2:8, acetone/
hexane, v:v; Rf = 0.18) to give a white solid (21% yield, mp 48–49 °C).
a
a
These results suggest that the phosphorylated
a-oximino acid 4
may exhibit the characteristics of slow-tight binding.14,15 Further-
more, the O-phosphoryloxime motif may serve as an alternative
zinc-binding group in the design of metalloprotease inhibitors.
13. Synthesis of phosphoryl oxime 4: THF (1 mL) was added to
a mixture of
precursor of 3 (46 mg, 0.083 mmol), 10% Pd/C (5.5 mg), and NaHCO3 (4.1 equiv,
28.4 mg, 0.338 mmol). The mixture was stirred vigorously, purged with argon
and hydrogen. Then, distilled H2O (0.4 mL) was added. The hydrogenolysis
reaction was run for 2.5 h at rt. The reaction solvent was filtered through a
Acknowledgments
0.2 lm PTFE micropore filtration disk (Whatman), removed in vacuo and
pumped overnight to yield white salts. Yield. Quantitative.
14. PSMA inhibition assay and IC50 determination: Inhibition studies were performed
as described previously with only minor modifications. Working solutions of
The authors would like to extend their gratitude to Greg Helms,
William Hiscox, and Jackie Zhu, and to the NMR facility and the
Laboratory for Bioanalysis and Biotechnology (LBB2) center at
WSU for their expert assistance. This work was supported by the
Krit Y. Hatton Memorial Fund and in fond memory is dedicated
to Krit Y. Hatton and the Hatton family.
the substrate (N-[4-(phenylazo)benzoyl]-glutamyl-
c-glutamic acid, PAB-Glu-
c
-Glu) and all inhibitors were prepared in Tris buffer (50 mM, pH 7.4). Working
solutions of purified PSMA were appropriately diluted in Tris buffer (50 mM,
pH 7.4) with 1% TritonX detergent to provide from 15% to 20% conversion of
substrate to product in the absence of inhibitor. A typical incubation mixture
(final volume 250
inhibitor solution or 25
(50 mM, pH 7.4) in a test tube. A volume of the 25
was added to the above-mentioned solution. The enzymatic reaction was
initiated by the addition of 25 L of the PSMA working solution. In all cases, the
final concentration of PABGlu- -Glu was while the enzyme was
incubated with five serially diluted inhibitor concentrations to provide
l
L) was prepared by the addition of either 25
L Tris buffer (50 mM, pH 7.4) to 175 L Tris buffer
L PAB-Glu- -Glu (10 M)
lL of an
l
l
c
Supplementary data
l
l
l
Supplementary data (NMR data for compounds 2a–j, 3, and 4)
associated with this article can be found, in the online version, at
c
1 lM
a
range of inhibition from 10% to 90%. The reaction was allowed to proceed for
15 min with constant shaking at 37 °C and was terminated by the addition of
25
by vortexing. The quenched incubation mixture was quickly buffered by the
addition of 25 L K2HPO4 (0.1 M), vortexed, and centrifuged (10 min at 7000g).
An 85 L aliquot of the resulting supernatant was subsequently quantified by
HPLC as previously described. IC50 values were calculated using KaleidaGraph
3.6 (Synergy Software).
lL methanolic TFA (2% trifluoroacetic acid by volume in methanol) followed
References and notes
l
1. Rodriguez, C. E.; Lu, H.; Martinez, A. R.; Hu, Y.; Brunelle, A.; Berkman, C. E. J.
Enzyme Inhib. 2001, 16, 359.
l
2. Maung, J.; Mallari, J. P.; Girtsman, T. A.; Wu, L. Y.; Rowley, J. A.; Santiago, N. M.;
Brunelle, A. N.; Berkman, C. E. Bioorg. Med. Chem. 2004, 12, 4969.
3. Hoshino, O.; Murakata, M.; Yamada, K. Bioorg. Med. Chem. Lett. 1992, 2, 1561.
4. Boehlow, T. R.; Harburn, J. J.; Spilling, C. D. J. Org. Chem. 2001, 66, 8.
5. Kotoku, N.; Tsujita, H.; Hiramatsu, A.; Mori, C.; Koizumi, N.; Kobayashi, M.
Tetrahedron 2005, 61, 7211.
15. PSMA preincubation inhibition studies: This assay was conducted as described
above for IC50 determination except that PSMA was preincubated with
inhibitor 4 (60 nM) for 10 min with constant shaking at 37 °C prior to the
addition of PABGlu-c-Glu.